ClinicalTrials.gg
BiologicalDrug

Platelet rich plasma clinical trials

Also written PRP.

studies test it
326
open now
62
in phase 3
63
first study started
2005

How each study uses platelet rich plasma is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the platelet rich plasma studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Platelet Rich Plasma
83
Platelet-Rich Plasma
34
PRP injection
27
Autologous Platelet-Rich Plasma (PRP)
13
Platelet rich plasma (PRP)
12

Other names

PRP
100
Autologous conditioned plasma
1

Studies by the year they started

325 studies that test it; most in 2019 (29); 1 more planned to start later

Studies that test platelet rich plasma, by start year
YearStudies
20052
20072
20084
20095
20106
20115
20126
201310
201416
201513
201621
201721
201820
201929
202021
202129
202220
202325
202424
202519
202627

By phase

A phase 1/2 study counts in both.

Early Phase 1
14
Phase 1
43
Phase 2
92
Phase 3
63
Phase 4
41
No phase
118

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 7 · Other 319

Assiut University (9) · Zagazig University (7) · Ain Shams University (6) · Meir Medical Center (6) · University of Miami (5) · Benha University (5) · Cairo University (5) · National and Kapodistrian University of Athens (4)

Often tested with

Tested in the same studies.

Hyaluronic Acid (13) · P-prf (4) · Glucose (3) · Methylprednisolone (3) · Triamcinolone Acetonide (2) · Triamcinolone (2) · Methylprednisolone Acetate (2) · Autologous bone marrow-derived mesenchymal stem cells (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 22, 3 in phase 3

Studies that test platelet rich plasma, phase 3 first.

Studies

Open first, then newest update. How each study uses platelet rich plasma is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 326

See all 326 studies that test platelet rich plasma →

Given beside what is tested · 12 — platelet rich plasma is usual care or a partner of the new treatment
As the comparator · 17 — what is tested is compared with platelet rich plasma

Codes

What other systems call platelet rich plasma · ClinicalTrials.gg INT018727

  • UNII (FDA) ZW1U5HYZ1APLATELET RICH PLASMAOne source FDA
  • NCI Thesaurus C177738Therapeutic Autologous Platelet-rich PlasmaOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.